Related Experiment Video
Updated: Apr 7, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.9K
Teleoncology for gynecologic cancers.
David I Shalowitz1, Allison G Smith2, Maria C Bell3
1Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, PA, United States.
Gynecologic Oncology
|July 8, 2015
Summary
Teleoncology, or remote cancer care, can improve access for women in rural areas facing geographic barriers to gynecologic oncology services. This approach is crucial for ensuring equitable, high-quality cancer care for all women, regardless of location.
Area of Science:
- Oncology
- Telemedicine
- Health Services Research
Background:
- Millions of women in the U.S. live far from gynecologic oncologists, creating significant access barriers.
- Geographic distance is a major challenge for receiving timely and high-quality gynecologic cancer care.
- Existing literature on teleoncology for gynecologic cancers, especially those requiring surgical intervention, is limited.
Purpose of the Study:
- To review existing data on telemedicine's role in cancer care.
- To assess the applicability of teleoncology for managing gynecologic malignancies.
- To share clinical experience in treating rural and underserved gynecologic cancer patients.
Main Methods:
- Literature review of telemedicine applications in oncology.
- Focused analysis on teleoncology for gynecologic cancers.
- Inclusion of case examples from clinical practice with rural/underserved populations.
Main Results:
- Telemedicine shows promise in overcoming geographic barriers to cancer care.
- Remote management strategies are being developed for various cancer types, including gynecologic malignancies.
- Clinical experience suggests feasibility in treating rural gynecologic cancer patients.
Conclusions:
- Teleoncology has the potential to significantly improve access to specialized gynecologic cancer care.
- Addressing the unique challenges of remote medical and surgical management is key.
- Developing robust teleoncologic systems is essential for equitable cancer care delivery.
Related Concept Videos
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers
1.5K
1.5K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies
1.8K
1.8K
Cancer Therapies
10.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K
Cancer Therapies
3.0K
3.0K

